It's because it was an unusual amount of spending for the quarter and expect it to go back to near normal cash burn rate (we only spent 5.8 million in the first half) so anywhere near that will get us back up above the 2 quarters required.![]()
- Forums
- ASX - By Stock
- NUZ
- Ann: Appendix 4C & Quarterly Update
NUZ
neurizon therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

Ann: Appendix 4C & Quarterly Update, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $81.23M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.5¢ | $7.296K | 44.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 225384 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 173985 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 223092 | 0.160 |
5 | 45203 | 0.155 |
3 | 221384 | 0.150 |
4 | 865247 | 0.145 |
3 | 78490 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 170799 | 5 |
0.175 | 177429 | 4 |
0.180 | 94474 | 1 |
0.185 | 125000 | 3 |
0.190 | 24925 | 2 |
Last trade - 10.36am 18/06/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online